Background: Medullary thyroid cancer (MTC) can be associated with significant morbidity
and mortality in advanced cases. Hence, we aimed to identify factors at the time of MTC …

This image is the first reported instance of medullary thyroid carcinoma (MTC), in which
[68Ga] Ga-DOTA-FAPI-04 provided a more accurate assessment of the disease's metastatic …

The new incretin-based therapies, dipeptidyl peptidase-4 (DPP4) inhibitors and glucagon
like peptide 1 (GLP1) receptor agonists are widely used for the treatment of type 2 diabetes …

Medullary thyroid carcinoma (MTC) accounts for only 5% to 10% of all thyroid carcinomas,
but it is the most aggressive form of well-differentiated thyroid carcinoma, being responsible …

Background This study aimed to explore the prognostic impact that the log odds of positive
lymph nodes (LODDS) has on medullary thyroid cancer (MTC) and to develop a nomogram …

BACKGROUND: Medullary thyroid microcarcinomas (microMTCs) are medullary thyroid
carcinomas (MTCs) that measure≤ 1 cm in size for which there is a paucity of data on …

PURPOSE We conducted a post hoc analysis of the vandetanib phase III trial involving
patients with advanced medullary thyroid cancer (MTC) to assess the efficacy and safety of …

Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant hereditary cancer
syndrome caused by missense gain-of-function mutations of the RET proto-oncogene. Three …

Metaiodobenzylguanidine, a guanithidine analog, labeled with 123I and 131I, is used for
imaging and therapy of neuroblastomas and various neural crest tumors like …

Multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant cancer syndrome
with major components of medullary thyroid carcinoma (MTC), pheochromocytoma and …